| Multiple Sclerosis Research Studies | Lifetime | 114 | DE 12 | 99.17 |
| Neuroinflammation and Neurodegeneration Mechanisms | Lifetime | 284 | DE 31 | 98.92 |
| Polyomavirus and related diseases | Lifetime | 136 | DE 9 | 98.43 |
| Peripheral Neuropathies and Disorders | Lifetime | 166 | DE 15 | 98.60 |
| Ion channel regulation and function | Lifetime | 868 | DE 65 | 97.62 |
| Autoimmune Neurological Disorders and Treatments | Lifetime | 257 | DE 34 | 93.66 |
| Myasthenia Gravis and Thymoma | Lifetime | 567 | DE 38 | 94.03 |
| Barrier Structure and Function Studies | Lifetime | 913 | DE 110 | 85.74 |
| Polyomavirus and related diseases | 2021-2025 | 4 | DE 2 | 99.44 |
| Multiple Sclerosis Research Studies | 2021-2025 | 12 | DE 3 | 99.69 |
| Peripheral Neuropathies and Disorders | 2021-2025 | 10 | DE 2 | 99.38 |
| Neuroinflammation and Neurodegeneration Mechanisms | 2021-2025 | 86 | DE 7 | 97.85 |
| Myasthenia Gravis and Thymoma | 2021-2025 | 41 | DE 7 | 96.64 |
| Immunotherapy and Immune Responses | 2021-2025 | 456 | DE 29 | 94.64 |
| T-cell and B-cell Immunology | 2021-2025 | 364 | DE 26 | 91.48 |
| Cytokine Signaling Pathways and Interactions | 2021-2025 | 197 | DE 13 | 85.58 |
| Neuroscience and Neuropharmacology Research | 2021-2025 | 910 | DE 72 | 88.38 |
| Autoimmune Neurological Disorders and Treatments | 2021-2025 | 122 | DE 15 | 89.88 |
| Rheumatoid Arthritis Research and Therapies | 2021-2025 | 709 | DE 49 | 90.39 |
| Cancer Treatment and Pharmacology | 2021-2025 | 671 | DE 32 | 87.96 |
| Neurogenesis and neuroplasticity mechanisms | 2021-2025 | 349 | DE 30 | 82.75 |
| Systemic Sclerosis and Related Diseases | 2021-2025 | 926 | DE 48 | 80.94 |
| Hereditary Neurological Disorders | 2021-2025 | 288 | DE 33 | 78.27 |
| Ion channel regulation and function | 2021-2025 | 780 | DE 45 | 78.08 |
| RNA regulation and disease | 2021-2025 | 687 | DE 39 | 73.74 |
| Inflammatory Myopathies and Dermatomyositis | 2021-2025 | 812 | DE 44 | 71.29 |
| Neurological Complications and Syndromes | 2021-2025 | 403 | DE 17 | 66.85 |
| Moyamoya disease diagnosis and treatment | 2021-2025 | 524 | DE 25 | 69.58 |
| Health and Medical Studies | 2021-2025 | 531 | DE 487 | 67.58 |
| Barrier Structure and Function Studies | 2021-2025 | 774 | DE 65 | 49.10 |
| Skin and Cellular Biology Research | 2021-2025 | 928 | DE 104 | 48.62 |
| Parkinson's Disease and Spinal Disorders | 2021-2025 | 548 | DE 35 | 40.89 |
| Cerebrovascular and genetic disorders | 2021-2025 | 783 | DE 27 | 34.26 |
| Apelin-related biomedical research | 2021-2025 | 758 | DE 31 | 32.31 |
| Calcium signaling and nucleotide metabolism | 2021-2025 | 941 | DE 95 | 31.73 |
